FDA announces Class 1 recalls for ventilators, LVAS monitors
Editor's Note The US Food and Drug Administration has announced class 1 recalls—the most severe category indicating risk of serious injury or death—for Abbot Medical’s HeartMate System Monitor and Philips Respironics OmniLab Advanced+ (OLA+) ventilator. According to the agency’s June 28 report, the recall of the HeartMate System Monitor, part…
Standardized handoff protocol improves OR communication
Editor's Note Findings published in the Journal of the American College of Surgeons show how a standardized handoff protocol can improve OR communication and reduce the risk of error, Medical Xpress reported on June 19. The study focused specifically on SHRIMPS, a standardized handoff protocol developed by the quality improvement…
FDA issues Class 1 recalls for two ventilator models
Editor's Note Alarm failures and missing details in instructional materials prompted the US Food and Drug Administration (FDA) to issue class 1 recalls—the most severe category indicating risk of serious injury or death—for two different ventilator models on June 27. According to the report, failure in the Ventilator Inoperative alarm…
Kidney transplant performed on awake patient
Editor's Note In a first for Northwestern Medicine, surgeons performed a kidney transplant on an awake patient, CBS News reported June 24. John Nicholas, 28, of Chicago, experienced no pain during the May 24 procedure, in which he received an organ from a childhood friend. He was discharged the next…
Study: Preoperative weight loss offers little benefit for bariatric surgery patients
Editor's Note Research shows perioperative weight loss does not consistently improve outcomes or OR times in patients undergoing primary bariatric procedures, including laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (RYGB). The findings were published in the June issue of the Journal of the American College of Surgeons. Using…
Study: Ozempic slows disease, reduces cardiovascular risk in CKD, diabetes patients
Editor's Note Semaglutide, the active ingredient in Ozempic diabetes treatment and Wegovy weight-loss treatment, outperformed a placebo and demonstrated capacity to reduce risk of death from kidney-related or cardiovascular causes in a recent study of patients with type 2 diabetes and chronic kidney disease spearheaded by manufacturer Novo Nordisk. Published…
Study: Weight-loss drug semaglutide boosts repeat surgery risk
Editor's Note Popular weight-loss \ drug semaglutide could significantly increase risk for repeat operations patients with diabetes who undergo lumbar surgery. According to a May 8 report in Medscape Medical News, the findings are pending review for publication and reportedly provides the first evidence on the impact of semaglutide on…
Majority of American adults have CKM syndrome, at risk for heart disease
Editor's Note Nine out of 10 American adults have Cardiovascular, kidney, and metabolic syndrome (CKM)—interrelated factors that progress to heart disease—and almost 10% already have heart disease, according to a report published in JAMA by Brigham and Women’s Hospital and Harvard Medical School in Boston. HealthDay news reported on the…
Data cast doubt on recommendation to delay weight-loss meds prior to surgery
Editor's Note A recent analysis of insurance claims data suggests weight-loss medications like Ozempic (semaglutide), Trulicity (dulaglutide), and other glucagon-like peptide-1 (GLP-1) receptor agonists do not increase risks associated with undergoing anesthesia. As reported April 22 in MedPage Today, these finding that contradicts a June 2023 recommendation from the American Society of…
FDA announces class 1 recall for disposable biopsy needle kit
Editor's Note Microscopic stainless steel debris on the insides of biopsy needles prompted the FDA to issue a class 1 recall—indicating risk of death or serious injury—for Elekta Instrument’s Disposable Biopsy Needle Kit, which is used with the Leksell Stereotactic System for brain tissue sampling during neurosurgery, the disposable biopsy…
Free Daily News
- Healthcare cybersecurity earns B+, but vulnerabilities remain
- FDA announces Class 1 recalls for ventilators, LVAS monitors
- Povidone iodine noninferior to chlorhexidine gluconate for preoperative skin antisepsis
- Standardized handoff protocol improves OR communication
- FDA issues Class 1 recalls for two ventilator models
- Study: Federal antitrust action minimal relative to number of hospital mergers
- Post-CABG cardiac shockwave therapy shows promise in early study
- Reassessing colonoscopy surveillance: Early- vs average-onset colorectal cancer
- Breaking down the anesthesia workforce imbalance, strategies to address crisis
- Study finds no link between anesthesia dose, postop delirium